SES Force-4, a division of premium engineering services provider Stress Engineering Services, will exhibit at DeviceTalks ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

C Medical Technologies announced today that it closed a Series D financing round resulting in gross proceeds of up to $175 ...

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

In the closing of the recent trading day, Boston Scientific (BSX) stood at $95.52, denoting a +1.48% change from the preceding trading day. Boston Scientific (NYSE:BSX) recently experienced a 4% ...

Boston Scientific Corp. closed 2.30% below its 52-week high of $107.17, which the company reached on February 5th.

Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Boston Scientific has gained a duo of CE markings in the European Union (EU) for its navigation enabled Farawave NAV Ablation Catheter for paroxysmal atrial fibrillation (AF) treatment and its new ...